Watchlist Price Alert

Protagonist Therapeutics ... (PTGX)

NASDAQ: PTGX · Real-Time Price · USD

54.66

-1.71 (-3.03%)

At close: Jun 16, 2025, 3:59 PM

55.00

0.63%

Pre-market: Jun 17, 2025, 05:10 AM EDT

Protagonist Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	434.43M	60M	26.58M	27.36M	28.63M	231K	30.93M	20.06M	n/a
Cost of Revenue	n/a	n/a	1.03M	2.77M	n/a	n/a	n/a	n/a	317K
Gross Profit	431.47M	60M	25.55M	24.58M	28.63M	231K	30.93M	20.06M	-317K
Operating Income	252.84M	-93.65M	-131.37M	-125.84M	-64.52M	-80.52M	-42.27M	-37.9M	-32.67M
Interest Income	26.32M	14.9M	4.06M	443K	900K	2.81M	2.57M	948K	242K
Pretax Income	279.41M	-78.95M	-127.39M	-125.55M	-64.84M	-77.88M	-39.72M	-36.96M	-37.18M
Net Income	275.19M	-78.95M	-123.41M	-122.63M	-66.15M	-77.19M	-38.92M	-36.96M	-37.18M
Selling & General & Admin	43.46M	33.49M	31.74M	27.2M	18.64M	15.75M	13.7M	11.78M	6.96M
Research & Development	138.13M	120.16M	126.22M	126.01M	74.51M	65M	59.5M	46.18M	25.7M
Other Expenses	n/a	n/a	-80K	-149K	-46K	-1K	n/a	n/a	-34K
Operating Expenses	181.59M	153.65M	157.95M	153.2M	93.14M	80.75M	73.19M	57.96M	32.67M
Interest Expense	n/a	n/a	n/a	n/a	598K	169K	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	181.59M	153.65M	157.95M	153.2M	93.14M	80.75M	73.19M	57.96M	32.67M
Income Tax Expense	4.22M	n/a	-3.98M	-2.92M	1.3M	-691K	-799K	-406K	4.16M
Shares Outstanding (Basic)	61.57M	56.76M	49.04M	46.32M	34.4M	25.89M	22.36M	17.69M	6.5M
Shares Outstanding (Diluted)	65.08M	56.76M	49.04M	46.32M	34.4M	25.89M	22.36M	17.69M	6.5M
EPS (Basic)	4.47	-1.39	-2.52	-2.65	-1.92	-2.98	-1.74	-2.09	-5.72
EPS (Diluted)	4.23	-1.39	-2.52	-2.65	-1.92	-2.98	-1.74	-2.09	-5.72
EBITDA	252.84M	-90.34M	-131.37M	-123.07M	-63.66M	-78.31M	-39.2M	-36.55M	-32.35M
EBIT	252.84M	-93.65M	-131.37M	-125.84M	-64.25M	-77.71M	-39.72M	-36.96M	-32.67M
Depreciation & Amortization	n/a	3.31M	1.03M	2.77M	789K	703K	527K	406K	317K